A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ernstoff, MS; Ma, WW; Tsai, FY-C; Munster, PN; Zhang, T; Kamoun, W; Pipas, JM; Chen, S; Santillana, S; Askoxylakis, V

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • TPS2604 - TPS2604

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.tps2604